Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Edwards Lifesciences Corporation Common Stock (EW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Edwards Lifesciences Corporation Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.59B), while Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $48.56B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 10.6× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| DFTX | EW | |
|---|---|---|
Market Cap | $4.59B | $48.56B |
Volume | 2,103,937 | 6,520,488 |
Sector | Health | Health |
52-Week High | $48.45 | $95.18 |
52-Week Low | $10.68 | $72.65 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $3.55B | $45.01B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →
